Connect with us

Business

Down Arrow Button Icon

Published

on



2025 saw some big names, like Circle, go public to rousing success. On the M&A side, blockbuster deals like Google’s $32 billion Wiz acquisition made headlines. 

But the hoped-for rising tide of exits did not come to lift all boats. Some IPOs, like Navan, met with more muted reception. And overall IPO activity, while up from recent lows, remains below historical levels.

As 2026 gets underway, the fundamental circumstances that influence private market exits are largely the same: Private companies are bigger than ever by valuation, but they also have more liquidity levers than ever to pull without needing to tap the public markets. But that privilege is reserved for the very best of breed. 

Further down the private company food chain, things are more complicated. Even for some promising AI startups, an acquihire to a giant is proving far more appealing than going at it alone. Which means acquisitions and other creative variations of dealmaking are also very much in play. 

Here’s how Term Sheet readers are looking at the exit landscape in 2026, and what they’re predicting for IPOs and M&A.

Note: Answers have been edited for clarity and brevity.

IPOs

IPO momentum will extend into early 2026, then slow. Right now, public equities are exceptionally strong, with high investor receptivity to tech, robust liquidity, and strong volume. There’s a four-year backlog of tech companies ready to go public, and this pent-up demand will continue releasing through Q1 or Q2 2026. But the window won’t stay open indefinitely. —Isabelle Freidheim, founder and managing partner, Athena Capital

The IPO market will continue to build on the successes of 2025. Our recent buyside discussions make it clear that the institutional market will be selective but look to put more capital to work behind their best ideas and grow with their winners. —Seth Rubin, Stifel head of global equity capital markets

Although the U.S./U.K. IPO markets are showing early signs of reawakening, optimism will remain measured. The opening of the IPO market will be a very significant event. The backlog is large and a positive trigger is needed to jumpstart the process of companies going public. —Ivan Nikkhoo, managing partner, Navigate Ventures

The IPO market will see more high-end, big-name companies go public as valuations improve, while smaller issuers will continue to struggle until meaningful reforms make the process more efficient and cost-effective. —Brad Bernstein, managing partner, FTV Capital

We expect 2026 to bring robust crypto-asset dealmaking generally, including M&A activity in the prediction markets and IPOs, as well as public tokenization transactions if we receive some helpful relief from the SEC on them. —Ben Cohen, partner, Latham & Watkins

With a choppy IPO window, [in life sciences] later-stage companies are staying private longer and often running dual-track M&A/go-public processes. Expect sustained high levels of activity in biotech and oncology sectors, both in earlier and later stage assets. —Mike Patrone, technology, life sciences, and private equity partner, Goodwin

Mergers and acquisitions

A $50B+ AI software acquisition reshapes the market. As a friendly regulatory environment continues and the financing capacity of incumbents grows—especially if they pull back from hyperscaler spending and free up tens of billions of dollars—I predict we’ll see a $50B+ AI software acquisition. —Jai Das, cofounder, president and partner, Sapphire Ventures

The deal environment will be more active, but larger buyout deals will likely be episodic and highly competitive.—Luke Sarsfield, CEO, P10 

In 2026, fintech will enter a phase defined by consolidation. The companies that achieve real product–market fit, strong unit economics, and defensible data advantages will pull decisively ahead, either by acquiring smaller players. —Ben Borodach, cofounder and CEO, April

I think we’ll see a lot of AI investment to help loss-related activities (FNOL, fraud detection, etc.). We’ll also continue to see private equity go after insurance distribution as a target sector while carriers keep snapping up inventive/creative new underwriters. —David Seider, CCO, TheZebra.com

2026 will mark the year of biotech coming back in vogue. Big pharma, with over $1 trillion in cash, will make significant acquisitions of venture-backed biotech companies focused on best-in-class therapies in oncology and metabolic diseases. —Steven Yang, head of global venture investments, Schroders

Cross border M&A as a percentage of global deal volumes is near a five-year high despite the trade wars and deglobalization headlines. Japan, which is undergoing an economic revitalization, will continue to shine under its new prime minister, Sanae Takaichi, corporate governance reforms and increasing interest from corporates and sponsors alike. —Michal Katz, head of investment and corporate banking, Mizuho Americas

M&A activity will remain robust, but the exit environment for the high multiple investments made in 2019 and 2021 will still be difficult. —Eric Zinterhofer, founding partner, Searchlight Capital Partners

Venture capital-backed startups will start to merge, making unlikely partners of firms who typically compete for deals. This trend, which started with a trickle in 2025, will accelerate as startups look for ways to sustain growth and achieve scale for a potential public listing or PE exit  —Arvind Purushotham, head of Citi Ventures

Secondaries, tenders, and more

A defining trend for 2026 will be the rise of secondary markets in private investing. As startups remain private longer and traditional IPOs become less frequent, investors are increasingly seeking liquidity solutions through GP-led continuation vehicles, structured secondaries, and other private-market mechanisms. —Kal Amin, managing partner, 1848 Ventures

Despite our belief that liquidity will return to private equity in 2026, we see the secondary market achieving a new transaction volume high in 2026 after the record volume seen in 2025. Why? Because we believe that as distributions come in so will capital calls, leaving many LPs still overallocated to private equity for a period to come. And that LPs will be more active in how they manage their private equity portfolios in good times and bad. Thus, we predict the secondary market will reach $250B in volume in 2026. —Yann Robard, managing partner, Dawson Partners

The secondary markets will get noisy. The ongoing IPO drought will collide with the boom in registered alternatives, further accelerating the expansion of the secondary marketinstitutional capital is still at the wheel as new retail capital steps on the gas. Get ready to compare notes on private company valuations at the neighborhood block party as premiums rise, positions change hands more rapidly, and a “hot potato” environment introduces new structural risk. —Larry Aschebrook, founder and managing partner, G Squared

In 2026, tender offers won’t be limited to the largest private companies. As talent competition intensifies and employees grow impatient with illiquidity, mid-stage companies will use tenders as a core morale and retention lever. Following the lead of ElevenLabs and Temporal, you’ll see more companies openly announce tenders as predictable liquidity becomes a competitive advantage. —Nick Bunick, principal, NewView Capital

With the economy growing at a somewhat surprisingly solid pace and inflation remaining elevated, the Fed has little reason – let alone urgency – to further cut rates. That means policy is unlikely to loosen much in the near term, keeping rates higher than many expected and possibly disappointing investors, unless inflation drops sharply or the job weakens unexpectedly. —Dr. Lindsey Piegza, Stifel chief economist

See you tomorrow, 

Allie Garfinkle
X:
@agarfinks
Email: alexandra.garfinkle@fortune.com
Submit a deal for the Term Sheet newsletter here.

Joey Abrams curated the deals section of today’s newsletter. Subscribe here.

VENTURE CAPITAL

DayOne Data Centers, a Singapore-based data center platform, entered into definitive agreements for $2 billion in Series C funding, led by Coatue and joined by others. 

interos.ai, an Arlington, Va.-based developer of supply chain risk management software, raised $20 million in funding from Blue Owl Capital and Structural Capital.

Unusual, a San Francisco-based platform designed to change how AI talks about brands and products, raised $3.6 million in funding from BoxGroup, Long Journey Ventures, Y Combinator, and others.

PRIVATE EQUITY

Align Capital Partners acquired Armko Industries, a Dallas-Fort Worth, Texas-based building envelope, roofing, and waterproofing consulting services. Financial terms were not disclosed.

J.C. Flowers acquired Elephant Insurance, a Richmond, Va.-based car insurance company. Financial terms were not disclosed. 

Oakley Capital acquired a majority stake in GLAS, a London, U.K.-based provider of loan administration and bond trustee services. La Caisse is also acquiring a minority stake. Financial terms were not disclosed. 

Wingman Growth Partners acquired a majority stake in InterProse, a Vancouver, Wash.-based developer of debt collection software. Financial terms were not disclosed.

EXITS

Bridgepoint agreed to acquire Interpath, a London, U.K.-based restructuring and financial advisory firm, from H.I.G. Capital. Financial terms were not disclosed.

Frontline Road Safety, a portfolio company of Bain Capital, acquired Surface Preparation Technologies, a New Kingstown, Pa.-based road safety company, from Dominus Capital. Financial terms were not disclosed.

TPG acquired a majority stake in Trustwell, a Beaverton, Ore.-based developer of regulatory, compliance, and traceability software for the food industry, from The Riverside Company. Financial terms were not disclosed. 

OTHERS

Coinbase agreed to acquire The Clearing Company, a San Francisco-based prediction markets company. Financial terms were not disclosed.

dormakaba agreed to acquire Avant-Garde Systems, a Clarksville, Ind.-based turnstile control company. Financial terms were not disclosed. 

IPOS

Aktis Oncology, a Boston, Mass.-based biotech company focused on solid tumors, plans to raise up to $212.4 million in an offering of 11.8 million shares priced between $16 and $18 on the Nasdaq. The company posted $6 million in revenue for the year ended Sept. 30. MPM BioImpact, Vida Ventures, EcoR1 Capital, and Blue Owl Capital Holdings back the company. 

FUNDS + FUNDS OF FUNDS

Antler, a Singapore-based venture capital firm, raised $160 million for its second fund focused on early-stage companies in AI and other sectors.

PEOPLE

Menlo Ventures, a Menlo Park, Calif.-based venture capital firm, promoted Deborah Carrillo to partner. 

Spectrum Equity, a Boston, Mass., San Francisco, and London, U.K.-based growth equity firm, promoted Michael Radonich and Matt Neidlinger to managing director. 



Source link

Continue Reading

Business

Down Arrow Button Icon

Published

on



Lawmakers sounded the alarm on the Justice Department’s criminal inquiry into Federal Reserve Chairman Jerome Powell, putting at risk President Donald Trump’s efforts to name a new central bank leader.

On Sunday, Powell revealed that the DOJ served the Fed with grand jury subpoenas, threatening a criminal indictment over his testimony before the Senate last June related to renovations on the headquarters, which has seen cost overruns.

He called the allegations a pretext and said the investigation was really aimed at the Fed’s ability to set interest rates without political pressure. Trump has attacked Powell for much of the last year over his reluctance to cut rates, though the president said he didn’t know about the DOJ probe.

But Republican Sen. Them Tillis agreed with Powell’s assessment and instead pointed the finger at the DOJ.

“If there were any remaining doubt whether advisers within the Trump Administration are actively pushing to end the independence of the Federal Reserve, there should now be none,” he wrote in a post on X. “It is now the independence and credibility of the Department of Justice that are in question.”

Tillis sits on the Senate Banking Committee, which oversees the Fed and would vote on anyone Trump tries to put on the central bank.

Powell’s term as chair expires in May, and Trump has said he already has someone in mind to replace him who will lower rates further. But the DOJ investigation into Powell could blow up that process.

“I will oppose the confirmation of any nominee for the Fed—including the upcoming Fed Chair vacancy—until this legal matter is fully resolved,” Tillis said.

While Powell’s term as chair expires in May, his term as a member of the Fed board of governors expires in 2028. When prior Fed chairs have stepped down, they typically have resigned from the board as well. Powell could choose to stay to preserve the Fed’s independence.

Sen. Elizabeth Warren, a Democrat who also sits on the Senate Banking Committee, accused Trump of trying to force Powell off the Fed board “to complete his corrupt takeover of our central bank.”

“He is abusing the law like a wannabe dictator so the Fed serves him and his billionaire friends,” she added. “The Senate must not move ANY Trump Fed nominee.”



Source link

Continue Reading

Business

Down Arrow Button Icon

Published

on



U.S. equity futures fell sharply Sunday night after Federal Reserve Chair Jerome Powell confirmed that he is under investigation related to testimony he gave last June concerning the renovation of Federal Reserve buildings. 

The New York Times report breaking news of the investigation and Powell’s subsequent disclosure rattled markets, reviving fears that years of President Donald Trump pressuring the Federal Reserve could now be realized into a direct assault on its independence.

Futures tied to the Nasdaq 100 led the decline, falling about 0.8%, as interest-rate-sensitive technology stocks bore the brunt of the selloff. S&P 500 futures were down roughly 0.5%, while Dow Jones Industrial Average futures fell about 0.4%, according to late-evening pricing.

Investors sought protection in the traditional safe-haven assets. Gold futures rose 1.7% to around $4,578 an ounce, while silver jumped more than 4%, reflecting renewed demand for protection against political and monetary instability. The U.S. dollar weakened modestly against several major currencies, including the Swiss franc and Japanese yen.

After years of largely staying silent while Trump repeatedly mocked and threatened him, Powell appeared to have reached a breaking point, issuing a rare and pointed statement. 

He wrote that while “No one—certainly not the chair of the Federal Reserve—is above the law,” the attack should be seen in the “the broader context of the administration’s threats and ongoing pressure.” 

“This new threat is not about my testimony last June or about the renovation of the Federal Reserve buildings…Those are pretexts. The threat of criminal charges is a consequence of the Federal Reserve setting interest rates based on our best assessment of what will serve the public, rather than following the preferences of the President.”

Economists warn that if the executive branch successfully co-opts the Fed, it could create a “self-fulfilling prophecy” of higher long-term inflation.

As Oxford Economics recently noted, any “cracks in the Fed’s independence” could spread rapidly through markets and ultimately raise borrowing costs for the businesses the administration seeks to protect with low interest rates. 

In a note published last July, when Trump publicly threatened to fire Powell, Deutsche Bank warned that such a move could spark severe market disruption.

“Both the currency and the bond market can collapse,” the bank wrote, citing heightened risks of inflation and financial instability. “The empirical and academic evidence on the impact of a loss of central-bank independence is fairly clear.”

Wall Street executives have echoed those concerns. Brian Moynihan, chief executive of Bank of America, said recently the erosion of Fed independence would carry serious consequences.

“The market will punish people if we don’t have an independent Fed,” Moynihan said.



Source link

Continue Reading

Business

Magnificent 7’s stock market dominance shows signs of cracking

Published

on



To beat the market in recent years, many investors applied a simple strategy: Load up on the biggest US technology stocks. 

It paid handsomely for a long time. But last year, it didn’t. For the first time since 2022, when the Federal Reserve started raising interest rates, the majority of the Magnificent 7 tech giants performed worse than the S&P 500 Index. While the Bloomberg Magnificent 7 Index rose 25% in 2025, compared with 16% for the S&P 500, that was only because of the enormous gains by Alphabet Inc. and Nvidia Corp.

Many Wall Street pros see that dynamic continuing in 2026, as profit growth slows and questions about payoffs from heavy artificial intelligence spending rise. So far they’ve been right, with the Magnificent 7 index up just 0.5% and the S&P 500 climbing 1.8% to start the year. Suddenly stock picking within the group is crucial. 

“This isn’t a one-size-fits-all market,” said Jack Janasiewicz, lead portfolio strategist at Natixis Investment Managers Solutions, which has $1.4 trillion in assets. “If you’re just buying the group, the losers could offset the winners.”

The three-year bull market has been led by the tech giants, with Nvidia, Alphabet, Microsoft Corp. and Apple Inc. alone accounting for more than a third of the S&P 500’s gains since the run began in October 2022. But enthusiasm for them is cooling as interest in the rest of the S&P 500 rises.

With Big Tech’s earnings growth slowing, investors are no longer content with promises of AI riches — they want to start seeing a return. Profits for the Magnificent 7 are expected to climb about 18% in 2026, the slowest pace since 2022 and not much better than the 13% rise projected for the other 493 companies in the S&P 500, according to data compiled by Bloomberg Intelligence.

“We’re already seeing a broadening of earnings growth and we think that’s going to continue,” said David Lefkowitz, head of US equities at UBS Global Wealth Management. “Tech is not the only game in town.”

One source of optimism is the group’s relatively subdued valuations. The Magnificent 7 index is priced at 29 times profits projected over the next 12 months, well below the 40s multiples earlier in the decade. The S&P 500 is trading at 22 times expected earnings, and the Nasdaq 100 Index is at 25 times. 

Here’s a look at expectations for the year ahead.

Nvidia

The dominant AI chipmaker is under pressure from rising competition and concerns about the sustainability of spending by its biggest customers. The stock is up 1,165% since the end of 2022, but it has lost 11% since its Oct. 29 record.

Rival Advanced Micro Devices Inc. has won data center orders from OpenAI and Oracle Corp., and Nvidia customers like Alphabet are increasingly deploying their own custom made processors. Still, its sales continue to race ahead as demand for chips outstrips supply. 

Wall Street is bullish, with 76 of the 82 analysts covering the chipmaker holding buy ratings. The average analyst price target implies a roughly 39% gain over the next 12 months, best among the group, according to data compiled by Bloomberg.

Microsoft

For Microsoft, 2025 was the second consecutive year it underperformed the S&P 500. One of the biggest AI spenders, it’s expected to invest nearly $100 billion in capital expenditures during its current fiscal year, which ends in June. That figure is projected to rise to $116 billion the following year, according to the average of analyst estimates.

The data center buildout is fueling a resurgence in revenue growth in Microsoft’s cloud-computing business, but the company hasn’t had as much success in getting customers to pay for the AI services infused into its software products. Investors want to start seeing returns on those investments, according to Brian Mulberry, client portfolio manager at Zacks Investment Management.

“What you’re seeing is some people looking for a little bit more quality management in terms of that cash flow management and a better idea on what profitability really looks like when it comes to AI,” Mulberry said.

Apple

Apple has been far less aggressive with its AI ambitions than the rest of the Magnificent 7. The stock was punished for it last year, falling almost 20% through the start of August. 

But then it caught on as an “anti-AI” play, soaring 34% through the end of the year as investors rewarded its lack of AI spending risk. At the same time, strong iPhone sales reassured investors that the company’s most important product remains in high demand. 

Accelerating growth will be the key for Apple shares this year. Its momentum has slowed recently, the stock closed higher on Friday, narrowly avoiding matching its longest losing streak since 1991. However, revenue is expected to expand 9% in fiscal 2026, which ends in September, the fastest pace since 2021. With the stock valued at 31 times estimated earnings, the second highest in the Magnificent 7 after Tesla, it will need the push to keep the rally going.

Alphabet

A year ago, OpenAI was seen as leading the AI race and investors feared Alphabet would get left behind. Today, Google’s parent is a consensus favorite, with dominant positions across the AI landscape. 

Alphabet’s latest Gemini AI model received rave reviews, easing concerns about OpenAI. And its tensor processing unit chips are considered a potential significant driver of future revenue growth, which could eat into Nvidia’s commanding share of the AI semiconductor market. 

The stock rose more than 65% last year, the best performance in the Magnificent 7. But how much more can it run? The company is approaching $4 trillion in market value, and the shares trade at around 28 times estimated earnings, well above their five-year average of 20. The average analyst price target projects just a 3.9% gain this year. 

Amazon.com

The e-commerce and cloud-computing giant was the weakest Magnificent 7 stock in 2025, its seventh straight year in that position. But Amazon has charged out of the gate in early 2026 and is leading the pack.

Much of the optimism surrounding the company is based on Amazon Web Services, which posted its fastest growth in years in the company’s most recent results. Concerns that AWS was falling behind its rivals has pressured the stock, as has the company’s aggressive AI spending, which includes efforts to improve efficiency at its warehouses, in part by using robotics. Investors expect the efficiency push to start paying off before long, which could make this the year the stock goes from laggard to leader. 

“Automation in warehouses and more efficient shipping will be huge,” said Clayton Allison, portfolio manager at Prime Capital Financial, which owns Amazon shares. “It hasn’t gotten the love yet, but it reminds me of Alphabet last year, which was sort of left behind amid all the concerns about competition from OpenAI, then really took off.”

Meta Platforms

Perhaps no stock in the group shows how investors have turned skeptical about lavish AI spending more than Meta. Chief Executive Officer Mark Zuckerberg has pushed expensive acquisitions and talent hires in pursuit of his AI ambitions, including a $14 billion investment in Scale AI in which Meta also hired the startup’s CEO Alexandr Wang to be its chief AI officer.

That strategy was fine with shareholders — until it wasn’t. The stock tumbled in late October after Meta raised its 2025 capital expenditures forecast to $72 billion and projected “notably larger”spending in 2026. When the shares hit a record in August they were up 35% for the year, but they’ve since dropped 17%. Demonstrating how that spending is boosting profits will be critical for Meta in 2026.

Tesla

Tesla’s shares were the worst performers in the Magnificent 7 through the first half of 2025, but then soared more than 40% in the second half as Chief Executive Officer Elon Musk shifted focus from slumping electric vehicle sales to self-driving cars and robotics. The rally has Tesla’s valuation at almost 200 times estimated profits, making it the second most expensive stock in the S&P 500 behind takeover target Warner Bros. Discover Inc.

After two years of stagnant revenue, Tesla is expected to start growing again in 2026. Revenue is projected to rise 12% this year and 18% next year, following an estimated 3% contraction in 2025, according to data compiled by Bloomberg.

Still, Wall Street is pessimistic about Tesla shares this year. The average analyst price target projects a 9.1% decline over the next 12 months, data compiled by Bloomberg show. 



Source link

Continue Reading

Trending

Copyright © Miami Select.